Page last updated: 2024-11-05

tinidazole and alpha-Chain Disease

tinidazole has been researched along with alpha-Chain Disease in 1 studies

Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dutta, U1
Udawat, H1
Noor, MT1
Sidhu, GS1
Kochhar, R1
Vaiphei, K1
Singh, K1

Other Studies

1 other study available for tinidazole and alpha-Chain Disease

ArticleYear
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
    Journal of gastrointestinal cancer, 2010, Volume: 41, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycyc

2010